POSA126 An Economic Analysis of Empagliflozin Versus Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction (HFREF) in the United Kingdom (UK)
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.269
https://www.valueinhealthjournal.com/article/S1098-3015(21)02064-7/fulltext
Title :
POSA126 An Economic Analysis of Empagliflozin Versus Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction (HFREF) in the United Kingdom (UK)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02064-7&doi=10.1016/j.jval.2021.11.269
First page :
Section Title :
Open access? :
No
Section Order :
11042